Skip to content

CellType

YC W26 · Active · The agentic drug company. We simulate human biology.

Competitors

Adjacent

Also from W26 in AI

All of W26

Founders

  • David van DijkFounder/CEO
  • Ivan VrkicFounder/CTO

About CellType

CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.

YC batch
W26 · Winter 2026
Status, per YC
Active
Category
AI
Team size
5
Location
New York City, NY, USA
Founded
2025
Checked
4h ago

CellType in W26: 199 companies, 80% AI

LinkedIn

CellType: questions

Which YC batch was CellType in?

CellType was in Y Combinator's Winter 2026 batch (W26).

Is CellType still active?

Y Combinator lists CellType as active.

Who founded CellType?

CellType's founders, as listed on its YC page: David van Dijk (Founder/CEO), Ivan Vrkic (Founder/CTO).

Where is CellType based?

CellType lists New York City, NY, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.